IL138292A - Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor - Google Patents
Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitorInfo
- Publication number
- IL138292A IL138292A IL13829299A IL13829299A IL138292A IL 138292 A IL138292 A IL 138292A IL 13829299 A IL13829299 A IL 13829299A IL 13829299 A IL13829299 A IL 13829299A IL 138292 A IL138292 A IL 138292A
- Authority
- IL
- Israel
- Prior art keywords
- medicament
- treating
- preventing
- aromatase inhibitor
- mammary carcinoma
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98104949A EP0943333A1 (de) | 1998-03-18 | 1998-03-18 | Medikament zur Prophylaxe und/oder Behandlung des Mammakarzinoms enthaltend einen Hemmer der Bildung von Oestrogenen |
PCT/EP1999/001374 WO1999047143A1 (de) | 1998-03-18 | 1999-03-03 | Medikament zur prophylaxe und/oder behandlung des mammakarzinoms enthaltend einen steroidalen aromataseinhibitor |
Publications (2)
Publication Number | Publication Date |
---|---|
IL138292A0 IL138292A0 (en) | 2001-10-31 |
IL138292A true IL138292A (en) | 2005-08-31 |
Family
ID=8231611
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13829299A IL138292A (en) | 1998-03-18 | 1999-03-03 | Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor |
Country Status (19)
Country | Link |
---|---|
EP (2) | EP0943333A1 (xx) |
JP (1) | JP4920822B2 (xx) |
KR (1) | KR100778803B1 (xx) |
CN (1) | CN1168448C (xx) |
AT (1) | ATE230995T1 (xx) |
AU (1) | AU751040B2 (xx) |
BR (1) | BR9908885A (xx) |
CA (1) | CA2324077C (xx) |
CZ (1) | CZ292643B6 (xx) |
DE (1) | DE59904042D1 (xx) |
DK (1) | DK1063998T3 (xx) |
ES (1) | ES2190201T3 (xx) |
HU (1) | HU226105B1 (xx) |
ID (1) | ID26965A (xx) |
IL (1) | IL138292A (xx) |
PL (1) | PL343100A1 (xx) |
RU (1) | RU2225206C2 (xx) |
SK (1) | SK285349B6 (xx) |
WO (1) | WO1999047143A1 (xx) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10042411A1 (de) * | 2000-08-30 | 2002-03-28 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System zur Abgabe von Exemestan |
DE10054294A1 (de) * | 2000-11-02 | 2002-05-16 | Heinrich Wieland | Topische Behandlung bei der Mastalgie |
JP4524296B2 (ja) * | 2007-03-30 | 2010-08-11 | 生化学工業株式会社 | 発毛促進剤 |
DE102007032468A1 (de) | 2007-07-10 | 2009-01-15 | Brätter, Christian, Dr. | Transdermale Therapeutische Systeme, welche den Wirkstoff Anastrozol enthalten |
US11850451B2 (en) | 2011-01-31 | 2023-12-26 | Lucolas-M.D. Ltd. | Cosmetic compositions and methods for improving skin conditions |
WO2012104240A2 (de) * | 2011-01-31 | 2012-08-09 | LUCOLAS-M.D. Ltd | Kosmetische verwendung |
EP2649994B1 (de) | 2011-01-31 | 2017-08-30 | LUCOLAS-M.D. Ltd. | Kombinationen von aromatase inhibitoren und antioxidanzien |
EP3666276A1 (en) * | 2018-12-14 | 2020-06-17 | dcic Biopharmaceutical Limited | Medication against estrogen-receptor beta (erbeta) positive breast tumor |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4235893A (en) * | 1978-05-08 | 1980-11-25 | Brodie Angela M | Ester derivatives of 4-hydroxy-4-androstene-3,17-dione and a method for inhibiting estrogen biosynthesis |
DE3322285A1 (de) * | 1983-06-18 | 1984-12-20 | Schering AG, 1000 Berlin und 4709 Bergkamen | 1-alkyl-androsta-1,4-dien-3,17-dione, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate |
FR2558373B1 (fr) * | 1984-01-20 | 1987-07-03 | Mauvais Jarvis Pierre | Medicament antioestrogene a base de 4-hydroxytamoxifene pour administration percutanee |
JPS6345294A (ja) * | 1986-04-07 | 1988-02-26 | Shionogi & Co Ltd | アロマタ−ゼ阻害ステロイド誘導体 |
EP0310542B1 (de) * | 1987-10-01 | 1994-06-08 | Schering Aktiengesellschaft | Antigestagen- und antiöstrogenwirksame Verbindungen zur Behandlung hormonabhängiger Tumoren |
FR2656310B1 (fr) * | 1989-12-22 | 1992-05-07 | Roussel Uclaf | Nouveaux produits sterouides comportant en position 10, un radical thioethyle substitue, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les renfermant. |
DE4039559A1 (de) * | 1990-12-07 | 1992-06-11 | Schering Ag | Funktionalisierte vinylazole, verfahren zu deren herstellung, pharmazeutische praeparate die diese vinylazole enthalten sowie deren verwendung zur herstellung von arzneimitteln |
GB9212833D0 (en) * | 1992-06-17 | 1992-07-29 | Glaxo Group Ltd | Chemical compounds |
DK0689536T3 (da) * | 1993-03-16 | 2001-07-30 | Pfizer | Naphthalenderivater |
JPH07215992A (ja) * | 1993-12-07 | 1995-08-15 | Teikoku Hormone Mfg Co Ltd | 6−又は7−置換アンドロスタ−1,4−ジエン誘導体 |
ATE197889T1 (de) * | 1994-09-14 | 2000-12-15 | Univ Sheffield | Kontrolle des haarwuchses |
US5780050A (en) * | 1995-07-20 | 1998-07-14 | Theratech, Inc. | Drug delivery compositions for improved stability of steroids |
AU1793397A (en) * | 1996-03-29 | 1997-10-22 | S.W. Patentverwertungs Ges. M.B.H. Edelsbacher U. Partner | Cosmetic or cosmetic preparation for smoothing and tightening the skin in the case of subcutaneous fatty tissue problems, particularly cellulite |
JP2000515523A (ja) * | 1996-07-22 | 2000-11-21 | ザ・ビクトリア・ユニバーシティ・オブ・マンチェスター | 創傷および線維性障害の治療における性ステロイド機能モジュレーターの使用 |
-
1998
- 1998-03-18 EP EP98104949A patent/EP0943333A1/de not_active Withdrawn
-
1999
- 1999-03-03 EP EP99913218A patent/EP1063998B1/de not_active Expired - Lifetime
- 1999-03-03 DE DE59904042T patent/DE59904042D1/de not_active Expired - Lifetime
- 1999-03-03 ID IDW20002095A patent/ID26965A/id unknown
- 1999-03-03 PL PL99343100A patent/PL343100A1/xx unknown
- 1999-03-03 HU HU0101005A patent/HU226105B1/hu not_active IP Right Cessation
- 1999-03-03 BR BR9908885-1A patent/BR9908885A/pt not_active Application Discontinuation
- 1999-03-03 CZ CZ20003256A patent/CZ292643B6/cs not_active IP Right Cessation
- 1999-03-03 AU AU31434/99A patent/AU751040B2/en not_active Expired
- 1999-03-03 KR KR1020007010177A patent/KR100778803B1/ko not_active IP Right Cessation
- 1999-03-03 SK SK1342-2000A patent/SK285349B6/sk unknown
- 1999-03-03 IL IL13829299A patent/IL138292A/xx not_active IP Right Cessation
- 1999-03-03 CA CA002324077A patent/CA2324077C/en not_active Expired - Fee Related
- 1999-03-03 WO PCT/EP1999/001374 patent/WO1999047143A1/de active IP Right Grant
- 1999-03-03 CN CNB998064009A patent/CN1168448C/zh not_active Expired - Lifetime
- 1999-03-03 AT AT99913218T patent/ATE230995T1/de active
- 1999-03-03 DK DK99913218T patent/DK1063998T3/da active
- 1999-03-03 RU RU2000126276/15A patent/RU2225206C2/ru active IP Right Revival
- 1999-03-03 JP JP2000536383A patent/JP4920822B2/ja not_active Expired - Lifetime
- 1999-03-03 ES ES99913218T patent/ES2190201T3/es not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE59904042D1 (de) | 2003-02-20 |
HU226105B1 (en) | 2008-04-28 |
JP2002506823A (ja) | 2002-03-05 |
RU2225206C2 (ru) | 2004-03-10 |
AU3143499A (en) | 1999-10-11 |
ES2190201T3 (es) | 2003-07-16 |
EP1063998A1 (de) | 2001-01-03 |
JP4920822B2 (ja) | 2012-04-18 |
CA2324077A1 (en) | 1999-09-23 |
CA2324077C (en) | 2008-07-29 |
ID26965A (id) | 2001-02-22 |
CZ292643B6 (cs) | 2003-11-12 |
EP0943333A1 (de) | 1999-09-22 |
DK1063998T3 (da) | 2003-05-12 |
EP1063998B1 (de) | 2003-01-15 |
CZ20003256A3 (cs) | 2001-04-11 |
BR9908885A (pt) | 2000-11-21 |
IL138292A0 (en) | 2001-10-31 |
HUP0101005A2 (hu) | 2001-08-28 |
CN1301165A (zh) | 2001-06-27 |
CN1168448C (zh) | 2004-09-29 |
SK285349B6 (sk) | 2006-11-03 |
AU751040B2 (en) | 2002-08-08 |
WO1999047143A1 (de) | 1999-09-23 |
KR100778803B1 (ko) | 2007-11-27 |
KR20010034603A (ko) | 2001-04-25 |
SK13422000A3 (sk) | 2001-05-10 |
ATE230995T1 (de) | 2003-02-15 |
PL343100A1 (en) | 2001-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ285159A (en) | Treatment of benign prostatic hyperplasia, endometriosis, prostatic carcinoma and obesity by administration of droloxifene | |
SI1556058T1 (sl) | Farmacevtski sestavki, ki obsegajo estetrolne derivate, za uporabo pri zdravljenju raka | |
IL150767A (en) | Benzophyrene compounds and their use in the manufacture of drugs for the treatment of estrogen-sensitive diseases such as endometrial cancer | |
PL338555A1 (en) | Method of preventing or treating oestrogen-dependent diseases and disorders | |
FR2791573B1 (fr) | Utilisation d'un extrait de serenoa repens pour la fabrication d'un medicament destine au traitement du cancer de la prostate | |
WO2002058706A3 (en) | Combination of an estrogen and an androgen for treating hormonal deficiencies in women undergoing estrogen replacement therapy | |
MY164077A (en) | Compositions and uses of et743 for treating cancer | |
MY112949A (en) | Benzo-thiaphene estrogen agonists to treat prostatic hyperplasia | |
IL138292A (en) | Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor | |
NZ504928A (en) | Combination of benzocycloheptapyridine compounds and antineoplastic drugs for treating proliferative diseases | |
UA72927C2 (uk) | Композиція для лікування печінково-клітинного раку, що містить доцетаксель | |
IL124881A0 (en) | Use of the l-enantiomer of centchroman for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of breast cancer | |
GB0008172D0 (en) | Therapy | |
PL357179A1 (en) | Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-mtdc) and/or physiologically compatible salts for treating and/or preventing cancers | |
NZ337048A (en) | Use of N-[1-methyl-(substituted phenyl)ethyl]-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide derivatives to treat prostate cancer | |
ZA200209835B (en) | Combined therapy against tumors comprising substituted acryloyl distamycin derivatives, taxanes and/or anti-metabolites. | |
CY1109852T1 (el) | Συμπληρωμα ασβεστιου για τον περιορισμο του κινδυνου καρκινου του προστατη | |
IT1314187B1 (it) | Combinazione di differenti composizioni farmaceutiche per iltrattamento del carcinoma mammario e relativo uso | |
EP1385497A4 (en) | METHOD FOR PREVENTING OR TREATING BREAST CANCER, PROSTATE AND / OR COLUMN OF UTERUS USING N, N-DIMETHYLGLYCIN | |
AU3145400A (en) | Preparation for the prevention and/or treatment of a tissue change of mesenchymal origin | |
NZ336321A (en) | Use of benzothiophene (raloxifene) for treating breast cancer | |
NZ516564A (en) | Cancer therapy | |
MX9709683A (es) | Uso de derivados de vitamina d4 para tratamiento contra el cancer. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees | ||
NE | Application for restoration - patent lapsed through non-payment of renewal fees (section 60, patents law, 5727-1967) | ||
KB | Patent renewed | ||
EXP | Patent expired |